Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia
· Delayed Price · Currency is SAR 131.60
0.00 (0.00%)
Mar 27, 2025, 3:14 PM AST
TADAWUL:4016 Revenue
In the year 2024, Middle East Pharmaceutical Industries Company had annual revenue of 394.00M SAR with 16.42% growth. Middle East Pharmaceutical Industries Company had revenue of 135.99M in the quarter ending December 31, 2024, with 5.28% growth.
Revenue
394.00M
Revenue Growth
+16.42%
P/S Ratio
8.58
Revenue / Employee
725.60K
Employees
543
Market Cap
2.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 394.00M | 55.56M | 16.42% |
| Dec 31, 2023 | 338.44M | 35.78M | 11.82% |
| Dec 31, 2022 | 302.66M | 15.44M | 5.38% |
| Dec 31, 2021 | 287.22M | -14.44M | -4.79% |
| Dec 31, 2020 | 301.66M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Sulaiman Al Habib Medical Services Group Company | 11.20B |
| Mouwasat Medical Services Company | 2.88B |
| Nahdi Medical Company | 9.45B |
| Dallah Healthcare Company | 3.21B |
| Jamjoom Pharmaceuticals Factory Company | 1.32B |
| National Medical Care Company | 1.29B |
| Al-Dawaa Medical Services Company | 6.45B |
| Al Hammadi Holding Company | 1.15B |